| 
                    
                        Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma
                    Por:
                    Lenfant, L, Breda, A, Xylinas, E, Babjuk, M, Moschini, M, Roupret, M, Board, TESOOUBESOUEPublicada:
                    1 ago 2022
                    Ahead of Print:
                    1 jul 2022
 
 
                        Resumen:
                        This case-based discussion describes the management of a 66-yr-old man who presented to the emergency department with gross hematuria. His urine cytology was benign, and computed tomography (CT) with nephrographic phase revealed a 2.5 cm filling defect within the left renal pelvis and luminal narrowing in the right proximal ureter with hydronephrosis. CT showed no lymphadenopathy and no sign of metastatic disease. Cystoscopy was normal. In a progressive case-based discussion fashion, we will discuss the diagnostic and treatment options with two different perspectives: (1) guidelines-based current standard of care and (2) an outlook on future perspectives using the latest scientific advances that may soon become the standard of care.
 Patient summary: This presentation of a real-life clinical scenario will be useful in describing the current standard of care and future perspectives regarding the diagnosis and treatment of upper urinary tract tumors. (C) 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.
 
 Filiaciones:
                    
                            
                            
                            Lenfant, L
 :
                             Sorbonne Univ, Hop Pitie Salpetriere, Urol,GRC ndeg5, Predict Onco Urol, Paris, France
 Breda, A
 :
                             Autonomous Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain
 Xylinas, E
 :
                             Paris Univ, Bichat Claude Bernard Hosp, Assistance Publ Hop Paris, Dept Urol, Paris, France
 Babjuk, M
 :
                             Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
 
 Charles Univ Prague, Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic
 
 Charles Univ Prague, Hosp Motol, Prague, Czech Republic
 Moschini, M
 :
                             Luzerner Kantonssp, Klin fair Urol, Luzern, Switzerland
 Roupret, M
 :
                             Sorbonne Univ, Hop Pitie Salpetriere, Urol,GRC ndeg5, Predict Onco Urol, Paris, France
 
 Sorbonne Univ, Hop Pitie Salpetriere, Predict Onco Urol, APHP,GRC ndeg5, 83 Blvd Hop, F-75013 Paris, France
 
 
                        
                     |